Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Lenalidomide × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 71 Lymphoma, Follicular 19 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, B-Cell, Marginal Zone 11 Recurrence 7 Lymphoma 7 Neoplasms, Plasma Cell 6 Lymphoma, Non-Hodgkin 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Neoplasms 5 Lymphoma, Mantle-Cell 5 Smoldering Multiple Myeloma 3 Neoplasm, Residual 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Lymphoproliferative Disorders 1

Interventions

Biopsy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 4 pembrolizumab 2 duvelisib 2 belinostat 2 X-Rays 2 Whole-Body Irradiation 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 ruxolitinib 1 fludarabine 1 enasidenib 1 cemiplimab 1 Triamcinolone 1 Tacrolimus 1 Spinal Puncture 1 Solutions 1 Rituximab 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1 Melphalan 1 MEDI-570 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡